John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$297M |
| 2 |
Bank of America
BAC
|
+$249M |
| 3 |
Oracle
ORCL
|
+$247M |
| 4 |
Microsoft
MSFT
|
+$246M |
| 5 |
Snap
SNAP
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$260M |
| 2 |
Merck
MRK
|
+$260M |
| 3 |
S&P Global
SPGI
|
+$233M |
| 4 |
Occidental Petroleum
OXY
|
+$221M |
| 5 |
Walmart Inc
WMT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 11.06% |
| 4 | Industrials | 10.41% |
| 5 | Consumer Discretionary | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gilead Sciences
GILD
$181B
| $198M | 0.65% |
3,205,895
+664,765
| +26% | +$41.2M |
|
27
Cisco
CSCO
$438B
| $197M | 0.65% |
4,614,598
+613,236
| +15% | +$29.4M |
|
28
Amgen
AMGN
$238B
| $196M | 0.65% |
803,833
-241,382
| -23% | -$59.2M |
|
29
EQT Corp
EQT
$33.6B
| $189M | 0.63% |
5,504,805
+1,608,261
| +41% | +$66.3M |
|
30
Mondelez International
MDLZ
$82.3B
| $186M | 0.61% |
2,998,376
+2,001,990
| +201% | +$126M |
|
31
Newmont
NEM
$139B
| $186M | 0.61% |
3,115,210
+2,912,613
| +1,438% | +$206M |
|
32
Intuitive Surgical
ISRG
$134B
| $179M | 0.59% |
891,399
+834,981
| +1,480% | +$196M |
|
33
Canadian National Railway
CNI
$78.5B
| $173M | 0.57% |
1,534,411
+761,711
| +99% | +$89M |
|
|
SCHW
34
Charles Schwab
SCHW
$194B
| $170M | 0.56% |
2,691,679
+2,675,816
| +16,868% | +$185M |
|
35
Illumina
ILMN
$33.1B
| $169M | 0.56% |
943,371
+863,329
| +1,079% | +$220M |
|
36
Linde
LIN
$225B
| $164M | 0.54% |
571,852
+450,256
| +370% | +$141M |
|
37
Intel
INTC
$476B
| $151M | 0.5% |
4,047,053
+2,857,372
| +240% | +$124M |
|
38
Kroger
KR
$35.5B
| $151M | 0.5% |
3,189,466
+3,130,979
| +5,353% | +$167M |
|
|
EA
39
DELISTED
Electronic Arts
EA
| $148M | 0.49% |
1,215,904
+193,117
| +19% | +$24.6M |
|
40
Norfolk Southern
NSC
$78.8B
| $146M | 0.48% |
640,161
+20,942
| +3% | +$5.14M |
|
41
Broadcom
AVGO
$1.75T
| $141M | 0.47% |
+2,906,500
| New | +$163M |
|
42
Marathon Petroleum
MPC
$101B
| $140M | 0.46% |
1,704,590
+1,358,241
| +392% | +$127M |
|
|
43
Snap
SNAP
$8.86B
| $140M | 0.46% |
+10,654,086
| New | +$243M |
|
44
Sociedad Química y Minera de Chile
SQM
$23.4B
| $139M | 0.46% |
1,666,496
+1,390,024
| +503% | +$122M |
|
45
Li Auto
LI
$12.8B
| $137M | 0.45% |
3,578,032
+2,320,705
| +185% | +$62M |
|
46
Johnson & Johnson
JNJ
$651B
| $137M | 0.45% |
769,982
+210,314
| +38% | +$37.5M |
|
47
Novartis
NVS
$302B
| $136M | 0.45% |
1,607,532
-324,422
| -17% | -$28.5M |
|
|
DOCU
48
DocuSign
DOCU
$11.8B
| $135M | 0.45% |
2,360,317
+877,558
| +59% | +$71M |
|
49
CVS Health
CVS
$119B
| $135M | 0.45% |
1,457,795
+1,370,692
| +1,574% | +$134M |
|
50
Prologis
PLD
$135B
| $133M | 0.44% |
+1,130,081
| New | +$156M |
|
Similar funds
John Overdeck's Q2 2022 Portfolio in Review
As of Q2 2022, John Overdeck held 3,177 positions worth $30.3B, down 11% from $33.9B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
John Overdeck deployed $2.33B of net new capital in Q2 2022, opening 628 new positions and adding to 764 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Merck, an estimated $260M trimmed.
- John Overdeck's largest Q2 2022 buy was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
- John Overdeck added most to Bank of America in Q2 2022, an estimated $249M increase.
- John Overdeck's biggest Q2 2022 reduction was Merck, cutting an estimated $260M.
- John Overdeck fully exited Tesla in Q2 2022, selling an estimated $260M.
- John Overdeck's ten largest holdings make up 8.2% of its $30.3B portfolio in Q2 2022.
- John Overdeck opened 628 new positions and closed 730 in Q2 2022.
- John Overdeck's portfolio value fell 11% quarter-over-quarter to $30.3B.
Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.